Hopefully if and when Ryoncil is approved, @Phaedrus, and can be made available for label extension to IBD patients, there will be less need for colorectal surgeons like Dr. Lightner. Can’t imagine it being a job for life for anyone.
Is there a need for a Chief Research/Clinical Officer or Chief Product Officer in this new paradigm for the company?
banter and General Discussion, page-9362
-
- There are more pages in this discussion • 1,135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.3¢ |
Change
-0.013(1.37%) |
Mkt cap ! $1.021B | |||
| Open | High | Low | Value | Volume |
| 90.5¢ | 90.5¢ | 89.5¢ | $1.583M | 1.763M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5167 | 90.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 90.5¢ | 77512 | 24 |
View Market Depth
| Last trade - 11.43am 08/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |